http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008049645-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d82de571f8a6ea172282c760db461f54
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
filingDate 2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b480fdb46032eb32f603dedf98848bf
publicationDate 2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008049645-A2
titleOfInvention Hydrates of erlotinib hydrochloride
abstract The invention relates to a crystalline erlotinib hydrochloride hydrate and to a process for making crystalline erlotinib anhydrate, which comprises crystallizing an erlotinib hydrochloride hydrate from an aqueous solution of erlotinib hydrochloride; and recrystallizing said erlotinib hydrochloride hydrate from a non-aqueous solvent system to form an anhydrous erlotinib hydrochloride of Form A, Form B, or Form E.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014023027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8440823-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593083-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8669265-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010109443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009024989-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009007984-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749048-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014118737-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103570634-A
priorityDate 2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007056244-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0134574-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9630347-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1044969-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408546
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226448266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13649
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407319186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229809112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7368
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407217
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2782639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2777991
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128134063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575326
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87581503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226448267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449192583

Total number of triples: 58.